Found: 307
Select item for more details and to access through your institution.
A confusing patient's history: small or large vessel vasculitis?
- Published in:
- 2010
- By:
- Publication type:
- Case Study
A novel imaging marker of cortical "cellularity" in multiple sclerosis patients.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-60497-6
- By:
- Publication type:
- Article
Changes in the Cerebrospinal Fluid and Plasma Lipidome in Patients with Rett Syndrome.
- Published in:
- Metabolites (2218-1989), 2022, v. 12, n. 4, p. N.PAG, doi. 10.3390/metabo12040291
- By:
- Publication type:
- Article
Interdisciplinary Risk Management in the Treatment of Multiple Sclerosis.
- Published in:
- Deutsches Ärzteblatt International, 2016, v. 113, n. 51/52, p. 879, doi. 10.3238/arztebl.2016.0879
- By:
- Publication type:
- Article
Fingolimod in children with Rett syndrome: the FINGORETT study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Reply.
- Published in:
- Annals of Neurology, 2011, v. 69, n. 6, p. 1064, doi. 10.1002/ana.22418
- By:
- Publication type:
- Article
Antigen-specific adaptive immune responses in fingolimod-treated multiple sclerosis patients.
- Published in:
- Annals of Neurology, 2011, v. 69, n. 2, p. 408, doi. 10.1002/ana.22352
- By:
- Publication type:
- Article
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria.
- Published in:
- Annals of Neurology, 2011, v. 69, n. 2, p. 292, doi. 10.1002/ana.22366
- By:
- Publication type:
- Article
Evidence for acute neurotoxicity after chemotherapy.
- Published in:
- Annals of Neurology, 2010, v. 68, n. 6, p. 806, doi. 10.1002/ana.22169
- By:
- Publication type:
- Article
Copeptin: A novel, independent prognostic marker in patients with ischemic stroke.
- Published in:
- Annals of Neurology, 2009, v. 66, n. 6, p. 799, doi. 10.1002/ana.21783
- By:
- Publication type:
- Article
Another complication of natalizumab treatment? Taking the challenge.
- Published in:
- Annals of Neurology, 2009, v. 66, n. 3, p. 264, doi. 10.1002/ana.21842
- By:
- Publication type:
- Article
Health-related quality of life in multiple sclerosis: effects of natalizumab.
- Published in:
- Annals of Neurology, 2007, v. 62, n. 4, p. 335, doi. 10.1002/ana.21163
- By:
- Publication type:
- Article
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”.
- Published in:
- Annals of Neurology, 2005, v. 58, n. 6, p. 840
- By:
- Publication type:
- Article
Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype.
- Published in:
- Journal of Neuroinflammation, 2015, v. 12, n. 1, p. 1, doi. 10.1186/s12974-015-0256-1
- By:
- Publication type:
- Article
Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype.
- Published in:
- Journal of Neuroinflammation, 2015, v. 12, n. 1, p. 1, doi. 10.1186/s12974-015-0256-1
- By:
- Publication type:
- Article
Varicella-Zoster Virus Infections in Patients Treated With Fingolimod.
- Published in:
- JAMA Neurology, 2015, v. 72, n. 1, p. 31, doi. 10.1001/jamaneurol.2014.3065
- By:
- Publication type:
- Article
Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression.
- Published in:
- JAMA Neurology, 2014, v. 71, n. 3, p. 306, doi. 10.1001/jamaneurol.2013.5993
- By:
- Publication type:
- Article
Detection of Cerebrospinal Fluid Leaks by Intrathecal Contrast-Enhanced Magnetic Resonance Myelography.
- Published in:
- JAMA Neurology, 2013, v. 70, n. 12, p. 1576, doi. 10.1001/jamaneurol.2013.744
- By:
- Publication type:
- Article
Interleukin 17F Level and Interferon Beta Response in Patients With Multiple Sclerosis.
- Published in:
- JAMA Neurology, 2013, v. 70, n. 8, p. 1017, doi. 10.1001/jamaneurol.2013.192
- By:
- Publication type:
- Article
Evolution of Cortical and White Matter Lesion Load in Early-Stage Multiple Sclerosis: Correlation With Neuroaxonal Damage and Clinical Changes.
- Published in:
- Frontiers in Neurology, 2020, v. 11, p. N.PAG, doi. 10.3389/fneur.2020.00973
- By:
- Publication type:
- Article
Impact of exposure to interferon beta-1a on outcomes in patients with relapsing-remitting multiple sclerosis: exploratory analyses from the PRISMS long-term follow-up study.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2011, v. 4, n. 1, p. 3, doi. 10.1177/1756285610391693
- By:
- Publication type:
- Article
The Janus face of CNS‐directed autoimmune response: a therapeutic challenge.
- Published in:
- Brain: A Journal of Neurology, 2002, v. 125, n. 11, p. 2379, doi. 10.1093/brain/awf241
- By:
- Publication type:
- Article
Variability in detection and quantification of interferon β-1b-induced neutralizing antibodies.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Design and construction of an innovative brain phantom prototype for MRI.
- Published in:
- Magnetic Resonance in Medicine, 2019, v. 81, n. 2, p. 1165, doi. 10.1002/mrm.27464
- By:
- Publication type:
- Article
Multicenter.
- Published in:
- Magnetic Resonance in Medicine, 2014, v. 71, n. 3, p. 1103, doi. 10.1002/mrm.24772
- By:
- Publication type:
- Article
P2.57: Modelling Time to Progression in Multiple Sclerosis.
- Published in:
- Biometrical Journal, 2004, v. 46, p. 149, doi. 10.1002/bimj.200490210
- By:
- Publication type:
- Article
No consensus about consensus?
- Published in:
- Neurological Research & Practice, 2021, v. 3, n. 1, p. 1, doi. 10.1186/s42466-021-00144-x
- By:
- Publication type:
- Article
Measuring treatment response to advance precision medicine for multiple sclerosis.
- Published in:
- Annals of Clinical & Translational Neurology, 2021, v. 8, n. 11, p. 2166, doi. 10.1002/acn3.51471
- By:
- Publication type:
- Article
Impact of complement activation on clinical outcomes in multiple sclerosis.
- Published in:
- Annals of Clinical & Translational Neurology, 2021, v. 8, n. 4, p. 944, doi. 10.1002/acn3.51334
- By:
- Publication type:
- Article
Levels of brain‐derived neurotrophic factor in patients with multiple sclerosis.
- Published in:
- Annals of Clinical & Translational Neurology, 2020, v. 7, n. 11, p. 2251, doi. 10.1002/acn3.51215
- By:
- Publication type:
- Article
Blood neurofilament light as a potential endpoint in Phase 2 studies in MS.
- Published in:
- Annals of Clinical & Translational Neurology, 2019, v. 6, n. 6, p. 1081, doi. 10.1002/acn3.795
- By:
- Publication type:
- Article
Neurofilament light chain serum levels correlate with 10‐year MRI outcomes in multiple sclerosis.
- Published in:
- Annals of Clinical & Translational Neurology, 2018, v. 5, n. 12, p. 1478, doi. 10.1002/acn3.638
- By:
- Publication type:
- Article
Brain atrophy and disability worsening in primary progressive multiple sclerosis: insights from the INFORMS study.
- Published in:
- Annals of Clinical & Translational Neurology, 2018, v. 5, n. 3, p. 346, doi. 10.1002/acn3.534
- By:
- Publication type:
- Article
Quantified CSF antibody reactivity against myelin in multiple sclerosis.
- Published in:
- Annals of Clinical & Translational Neurology, 2015, v. 2, n. 12, p. 1116, doi. 10.1002/acn3.264
- By:
- Publication type:
- Article
Comparative efficacy of switching to natalizumab in active multiple sclerosis.
- Published in:
- Annals of Clinical & Translational Neurology, 2015, v. 2, n. 4, p. 373, doi. 10.1002/acn3.180
- By:
- Publication type:
- Article
Molecular mechanism underlying the impact of vitamin D on disease activity of MS.
- Published in:
- Annals of Clinical & Translational Neurology, 2014, v. 1, n. 8, p. 605, doi. 10.1002/acn3.91
- By:
- Publication type:
- Article
Biomarkers of treatment response in patients with progressive multiple sclerosis treated with high‐dose pharmaceutical‐grade biotin (MD1003).
- Published in:
- Brain & Behavior, 2021, v. 11, n. 2, p. 1, doi. 10.1002/brb3.1998
- By:
- Publication type:
- Article
Death Anxiety and Attitudes towards Death in Patients with Multiple Sclerosis: An Exploratory Study.
- Published in:
- Brain Sciences (2076-3425), 2021, v. 11, n. 8, p. 964, doi. 10.3390/brainsci11080964
- By:
- Publication type:
- Article
Mental health problems in children of somatically ill parents, e.g. multiple sclerosis.
- Published in:
- European Child & Adolescent Psychiatry, 2007, v. 16, n. 3, p. 199, doi. 10.1007/s00787-006-0589-5
- By:
- Publication type:
- Article
Use of pragmatic randomized trials in multiple sclerosis: A systematic overview.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 4/5, p. 463, doi. 10.1177/13524585231221938
- By:
- Publication type:
- Article
Optical coherence tomography versus other biomarkers: Associations with physical and cognitive disability in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 13, p. 1540, doi. 10.1177/13524585231198760
- By:
- Publication type:
- Article
Efficacy and safety of four-year ofatumumab treatment in relapsing multiple sclerosis: The ALITHIOS open-label extension.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 11/12, p. 1452, doi. 10.1177/13524585231195346
- By:
- Publication type:
- Article
Anterior horn atrophy in the cervical spinal cord: A new biomarker in progressive multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 6, p. 702, doi. 10.1177/13524585221139152
- By:
- Publication type:
- Article
Plasma neurofilament light chain in children with relapsing MS receiving teriflunomide or placebo: A post hoc analysis of the randomized TERIKIDS trial.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 3, p. 385, doi. 10.1177/13524585221144742
- By:
- Publication type:
- Article
Recurrent disability progression endpoints in multiple sclerosis clinical trials.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 1, p. 130, doi. 10.1177/13524585221125382
- By:
- Publication type:
- Article
Otto van Eikema Hommes – 7 February 1932 – 16 August 2022.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 1, p. 6, doi. 10.1177/13524585221139153
- By:
- Publication type:
- Article
Paramagnetic rims are a promising diagnostic imaging biomarker in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 14, p. 2212, doi. 10.1177/13524585221118677
- By:
- Publication type:
- Article
Overall Disability Response Score: An integrated endpoint to assess disability improvement and worsening over time in patients with multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 14, p. 2263, doi. 10.1177/13524585221114997
- By:
- Publication type:
- Article
Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Up to 5 years of follow-up in the DAYBREAK open-label extension trial.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 12, p. 1944, doi. 10.1177/13524585221102584
- By:
- Publication type:
- Article
Ocrelizumab reduces thalamic volume loss in patients with RMS and PPMS.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 12, p. 1927, doi. 10.1177/13524585221097561
- By:
- Publication type:
- Article